Licensing criteria for influenza vaccine immunogenicity laid down by the European Committee for Medicinal Products for Human Use.
收藏NIAID Data Ecosystem2026-03-07 收录
数据链接：
官方服务：
资源简介：
1Either a pre-vaccination HI titer<1∶10 and a post-vaccination HI titer ≥1∶40 or a pre-vaccination HI titer ≥1∶10 and a minimum four-fold rise in post-vaccination HI antibody titer.
创建时间：
2013-08-16
